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Epidermal keratinocyte growth and differentiation are 
regulated by specific families of growth factors and 
receptors. Peptide growth factors of the epidermal growth 
factor family stimulate proliferation of donal density 
hun'lan keratinocytes and suppress n1arkers of tern'linal 
differentiation in confluent cultures of hurnan ker-
atinocytes. We present evidence that selected inhibitors 
of activation of the type I human epidennal growth 
factor receptor (EGFR or HER-1), namely, neutralizing 
monoclonal antibody to HER-1/EGFR and the specific 
tyrosine kinase inhibitor PD 153035, potently inhibit 
proliferation of human keratinocytes in autonon'lously 
replicating subconfluent cultures. Coupled to growth 
arrest is the suppression of HER- 1 tyrosine autophos-
phorylation in inhibitor-treated human keratinocytes. 
Proliferation and tyrosine autophosphorylation are 
T he epidermis is a stratified squamous epithelium con-sisting primarily of keratinocytes and is orga nized in to disc rete layers of basal , replicative cells, and suprabasal la yers that undergo stringently regula ted prograrn(s) of terminal difle rentiation as cells move outward to the 
str~1tum corneum (Eckert, 1989; Fuchs and Byrne, 1994). Epidermal 
keratinocytes exhibit autoregulatory growth control mechanisms that 
coordinate proliferation and differentiation in seru m-free and defined 
culture conditions i11 11i tro (Shipley eta/, 1986; Cook ct 11/, 199l b). 
Upon culture conflu ence, keratinocytes initiate growth arrest, become 
co mmitted (irreversibly lose clonal growth potential), and express 
termina.l ditl:e rentiation gene products such as kerati n ·1 (K I) and 
keratin 10 (KJ 0) (Poumay and Pittdkow, 1995). 
Specific growth factors of the epidenna] growth facto r (EGF) 
family and their relevant receptors have been identified as the major 
autoregulatory c,c tors that are ex-pressed by keratinocytes and mediate 
cell proliferation , modulate terminal differentiat ion, and control overa l.l 
epiderma l homeostasis (R.hein wald and Green, 1977; Cofiey ct a!, 
1987; Cook ct a/, 199'1 b; Pittelkow ct a/, 1993). The type 1 EGF 
receptor (EGFR) or human EGF receptor (HER-'1) is a 170-kDa 
transmembrane receptor tyrosine kinase expressed within the epidermis 
by keratinocytes and many other epithelial tissues and ce ll types 
(Nanney ct a/, '1984; Wille el a/, :1984; Green and Co uchman, 1984; 
Carpenter and Wah l, '1990). Evidence fi·om this laboratory and others 
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initially reversible following removal of the inhibitor 
and resthnulation of cells with epidermal growth factor. 
Sustained inactivation ofHER-1 in autonomously replic-
ating cultures ofhmnan keratinocytes induces expression 
of keratin 1 and keratin 10 genes, early markers of 
terminal differentiation. Reversal of growth inhibition b y 
epidermal growth factor suppresses keratin 1 and keratin 
10 expression. These results detnonstrate that hmnan 
keratinocyte terminal differentiation as well as prolifera-
tion are rnediated by HER-1. Co- expression of autocrine 
epidermal growth factor-related ligands as well as HER-
1 by human keratinocyte may function as part of the 
signal transduction network in epidermis to regulate cell 
num.ber, replication rate, and tenninal differentiation. 
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implicates a critical rol e for H.ER-1 in cellular control of proliferation , 
ceLl cycle growth arrest, conunitmenr, and ditl:eren tiation (Wille cr a/, 
1984; Pittelkow et nl, "1993; Poumay and Pittelkow, 1995). 
Several of the EGF-related ligands including transforming growth 
f.Ktor-a, amphiregulin, and heparin hinding-EGF are expressed by 
cuJt.med keratinocytes, epidermis, and other epithelial cell types (Cofley 
ef nl, 1987; Cook ef a/, l 99 la ; Hashimoto eta/, J 994). T hese ligands 
exert auto-stimul;ltory or ;wto- regulatory activirjes in keratinocytes 
making th em candidate autocri ne liga nds for this epithelial cell type 
(Pittelkow ct a/, 1993). Co-expression of several EGF-rebted ligands 
and a cognate receptor, H.ER- 1, by kerati nocytes may explain , in part, 
previous observatio ns in our laboratory that proliferation of es tablished 
colonies of keratinocytes i11 11itro (clonal ex pansion) does not requi re 
exogenous sources of growth factors. T his phenomenon has been 
designated "autonomous" growth (Pittelkow l' t nl, 1993). By contrast, 
ini tia l colony fo rmation (clonal initiation) by single keratinocytes 
requires exogenous add ition of EG F or EGF-rebted ligands such as 
transforming growth E1ctor- a or amp hiregu.lin to defi ned culture 
medium. 
T he rol e of EG F-rclated liga nds and a cognate receptor, HER-1 , in 
stimu.latin g keratinocyte proliferati on is weLl es tablished (IX/ille ct a!, 
1984; Pittelkow ct nl , 1993); however, th e fu nction of EGF-related 
ligands and HER- l in mediatin g or modulating keratinocyte growth 
arrest (reversible inhibition of proli feration), ceLl commitment (in·evers-
ible growth arrest), and dif:Ie rentiation is poorly char~cterized. The 
redundancy of expression of EGF-related ligands by autonomously 
repli cating keratinocytes limits the abi li ty to specifica lly inhibit th e 
biologic activity of this growth f., ctor f.,m ily in these ceLl s. We therefore 
exa m.ined th e alternative approJ ch to interru pt autocrin e activity at 
th e receptor level usin g highly specifi c pharmacologic inhibitors of 
HER-1 ty ros ine kinase activity o r neutralizing antibody to ligand 
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Figure L Concen t ra ti o n-depen dent in hibition of replicatio n b y PD 153035 or EGFR MoAb . 131-l]Thymidine inco rpo ratio n assay of subco nAuent 
keratinocytes trea ted with PO 153035 or EGFR MoAb at des ignated concentrations. (a) PO '153035 or (b) .EGFR M oAb treatment for 48 h. (c) Comparison o f 
DNA synthesis inhibition by PO 153035 and EGFR Mo Ab at 12, 24, and 48 h. (1Q N o effect o f EG F (0.5 nM ) on PO 153035-treatcd keratinocytes (24 h). 
131-l]Thymidine incorporatio n performed as described in Materials 011d Methods. Error bars, mean ± SI . *Signifi cant difference, p < 0.05. 
binding of HER- 1. In this regard, we have previously shown that a 
monoclonal antibody (MoAb) to HER-1 inhibits Liga nd binding and 
strongly inhibits growth of keratinocytes (Pittelkow er al, 1993). In 
addition , a highly specifi c small molecule inhibitor of EGFR tyrosine 
kinase , 4-((3-bromophenol)amino ]-6, 7 -dimethoxyqu inazoline (PD 
153035), has demonstrated potent inhibition ofEGFR autophosphoryl-
ation in A431 human epidermoid carcinoma cells (Fry el al, 1994). 
Using EGFR MoAb or PD 153035, we examined the effects of HER-
1 inhibition on cell growth, commitment, terminal differentiation , and 
tyrosine kinase-mediated autophosp horylation of HER-1 in human 
keratinocytes and showed that ligand bind ing and kinase activiti es of 
HER-1 mediate keratinocyte commitment and tenninal differentiati on 
in addition to cell proliferation. 
MATERIALS AND ME THODS 
C ultu re of norn1al h uman kera t inocytes and reagen ts Human kcr-
atinocy tes were iso lated from neonatal fo reskin specimens, and cel l cu ltures 
were maintained in an undifferentiated, replicative state by growth and passage 
at subconBuence in complete, serum- free M C DB 153 medi um (Wille eta/, 
1984). Complete MC DB 153 medium contains 0. 1 mM calcium and is 
supplemented with 0.2% (vol/vol) bovine pituitary extract, .EG F (10 ng per rnl), 
and insulin (5 ~Jog per ml). Standard M C DB 153 was prepared by excluding 
bovine pitu itary extract, .EG F, and insulin fi·om the culture medium . Cu ltures 
of autono mously growing human keratinocytes were prepared by was hi ng 
cells propagated in complete medium with standard medium and refeeding 
subconAuent cell cultures with standard medium. C lonaJ growth assays were 
performed as prev iously described with keratinocytes grown in clefln ecl MC OB 
153 medium comaining EG F and insulin (Wille r l 11/, '1984). PO 153035 was 
obtained fi·om Parke-Davis (Ann Arbor, M l). EG FR./ I-IER- 1 neutrali zing 
MoAb (LA 'l) was purchased from Upstate Biotechnology (Lake Pbcid , NY). 
D NA syn thesis assay Keratinocy tes were grown to - 70% of conAu ence in 
24- well plates contai ning complete medium , switched to standa rd M COI3 153 
medium, incubated for 24 h, and then treated as indica ted. Following in hibi tOr 
treatm ent for 12, 24, or 48 h in culture, DNA synthetic activity was measured 
by [31-ljth ymidine inco rpo ratio n. T wo !J.C i 13 1-l lth ymid ine per ml was added 
to wells fo r 2 h, and incorporation o f radioacti vity into DNA was determined 
by prec ipitati on o f nuclea r ex rrac t with tri chlo roace ti c acid, so lubili zatio n in 
NaOH , and liquid sc inti ll atio n specu·oscopy (Cook ct nl, 199 '1 b). Va lues represent 
the mean cpm per well of at least trip li cate determ inations. 
RNA isolatio n an d northern blo t analysis l'o ly(A) R.NA was isolated 
from keratinocyte cultures by a mod ifi ed method o f Schwab ct 11/ as previo usly 
described (Pittelkow et nl, 1989). After resolution on 1.2% agarose-forma lcl ehyde 
gels and transfer, the membranes we re hybridi zed at 43°C with randoml y 
primed DNA probes labeled with la -32 Pici CTP. The probes included eDNA 
spec ifi c for the hurmn K 1 or K 1. 0 suprabasal keratins (Poumay and Pittclkow, 







Figure 2. Loss of clonogcnicity of keratinocytes following PD 153035 
or EGFR MoAb treatment. Kernt.inocyte culture.l were grown in stnJrdard 
medium ofter switching from complete medium 48 h earli er. Autonomously 
proli fernring cu.lturcs were untrea ted (control) or pretreated with PD 153035 
(250 nM) or EGFR MoAb (3 ~lg per ml) for 24 or 48 h. Cells were then 
trypsinized, washed, and replated without inhibitors at clonal density (500 cells 
per 60-mm dish) in complete MCDB 153 medium. After 10 d, culture plates 






Figure 3. PD 153035 and EGFR MoAb induce K1 and K10 gene 
expression in subconfluent kcratinocytcs . Autonon1ous cul tures of 
subconfluent kerati nocytes (standard medium) were tren ted with PI) :153035 
(250 nM) or EGFR MoAb (3 ].lg per nu) for 24 or 48 h, and poly(.A) mll...NA 
was extracted. Five micrograms of each sample was used for northern blot 
hybridization with probes fm K1 , Kl 0, or ·tB15 transcripts. 
1995). High stringency washes (0. 1 X sodium citrate/ chloride bull'er/ 0.1 % 
sodium dod~cy l sul f.1te at 65°C) were applied to the hyb ridized membranes 
before autor:rdiographic exposure. Each membrane was also hybri.di zcd with an 
identi ca lly labeled 1B IS eDNA probe for the constituitively expressed cyclophi-
lill gene to assur~ equi valent lo::.ding and transfer of I\_NA. Quantitati ve 
densitometric :r nai )'Sis was perfor'l11 ed on a Schimadzu CS9000U densitometer 
(Columbia , MD). 
Tyrosine phosphorylation ofHER-1 Celllysa tes were obtai ned by scrap ing 
keratinocytc cultures (60 or ·1 00 mm dishes) into I ml of Frackel ton bu fFer. 
Following centrifugation fo r 5 ntin , supernates were treated with 10 ~I of 
MoAb to EGFR/ HER.- 1 (LA '!) coupled to Protein G-Plus Agarose beads 
('IS].!]). Beads were rocked fo r several hours and repeatedl y washed before 
adding 20 ].!] of sample buffer, incubating the IHixture at I 00°C for 5 rnin , and 
separating th e irnrnunoprecipitate frorn the beads by centrifugation. Sampks 
were separated electrophoretic:r lly by I 0% sodium dodecyl sulf.1te polyJCrylamide 
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Figure 4. Modulation of Kl mRNA expression by PD 153035, EGF, 
and cell continence. K I and lB 15 rnRNA expression were determined by 
northern blot analysis under different conditions in subconfluent or confluent 
cultures of kera tinocytes. Ll111c 1, untreated, subconflu ent cells; /nne 2, PD 
153035 (250 mM). 24 h; la11c 3, PD '153035 (250 mM), 24 h and EGF (10 ng 
per ml), 4 h ; lam' 4, PD 153035 removed and EGF (10 ng per ntl), 4 h; lane 
5, con.flu ent cell ~ grown in standard medium, 24 h confluence; /nne 6, same as 
/nne 5 with addition of PD 153035 (250 mM). 24 h; lmre 7, same as lane 5, 
48 h confluence ; /nne 8, same as /nne 7 with PD 153035 (250 nM), 48 h. 
Northern blotting was performed as described in Fig 3 and Mnlerinls and 
Metlrorls. llatios of K I to ·1 Bl 5 were determined by quantitative densitometry 
using a Shimadzu CS9000U densitometer and nom1alizing to K t rnR.NA levels 
for subconAuent control (lane 2) or confluent, PD 1 53035- treated (lane 8) 
keratinocyte cultures. 
gel electrophoresis. After transfer to immobilon (MiHipore, Marlborough, MA), 
the membrane was blocked with 2% bovine serum albumin and exposed to 
anriphosphotyrosine antibody (PY20) (Transduction l abo rato1ies, Lexington, 
KY) coupled to peroxidase . Phosphotyrosine containing HER-·t was visualized 
with ECL detection system (Amersham , Arlington Heights, IL) and autor.1 dio-
gr:1 phy. 
RESULTS 
PD 153035 and EGFR MoAb inhibit keratinocyte DNA synthesis 
in a concentration- dependent 111anner W e initially sought to 
dete rmin e the efl:ects ofHER- l inhibition on keratinocyt e growth. PD 
153035 and EG FR Mo Ab treatment both dem onstrated concentration-
dependent inhibitio n of DNA synth esis by 48 h (Fig 1a,b). Significant 
(> 95%) inhibitio n was observed at 250 nM of PD 153035 and 3 !lg 
EGFR MoAb pe r ml , and greater than 99% inhibition was obser·vt'd 
at 500 nM of PD 153035. Inhibition of DNA synthesis was exerted as 
early as 1.2 b by both agents, w ith th e onset o f inhibition occming 
more promptly with PD 153035 (Fig 1c). The inhjbito ty efFect o fPD 
153035 (250 uM) could not be reversed by addition ofEGF (Fig td) . 
N o cell tOxicity was o bserved with PD153035 or EGFR M oAb, and 
DNA synthesis completely recovered within 24 h following removal 
of PD 1.53035, at concentrati ons as high as 10 11M (data no t shown). 
T herefore, both compou nds are potent, nontoxic, and initially revers-
ible inh"ibitors of keratinocyte replication . 
Loss of clonogenic potential by pretreatment with PD 153035 
or EGFR MoAb Inhibition of autonomous proliferati on in subcon-
llu ent cultures of ke ratinocytes has been identifi ed as reversible o r 
irreversible by donal growth assay (Pittelkow era/, 1986). Following 
pretreatment of au tOnomously g ro wing keratinocytes for 24 h with 
eithe r PD 153035 (250 nM) or EGFR M oAb (3 !lg per ml) and re-
p lating celts at dona.! density, a significant decrease in clonogenicity 
was observed th<lt was more marked for PD 153035 than for EGFR 
M oAb (Fig 2). Forty-eight hours ofpretreatment showed complete Joss 
of colony-forming potentia l for PD :1 53035 indica ting that keratinocyte 
commitment was indu ced at an accelera ted rate for this inhibitor 
compared with EGFR Mo Ab. Th erefore, a large m:lj o rity of proli ferat-
ive keratinocytes ~re committed to irreversible growth arrest within 
24 h, and clo nogenic potential is dependent on the ligand- binding and 
kinJse activities of HER-l. 
PD 153035 induces differentiation in subcontluent human ker-
atinocytes more rapidly than EGFR MoAb We next examined 
w hether these inhibitors m ediate direct efl:ects on keratinocyte tennirul 
differentiation. Northern analysis showed that addition of PD 153035 
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Figure 5. Suppression of HER-1. autophosphorylation by PO · J3035 in subconflucnt or confluent kcratinocytc cultures. (11) PD "153035 (500 nM) 
exposure of subconAuent autonomously replica ting keratinocytes for ll, 12, or 24 h. (b) SubconAuent cul tures were treated either with PD 153035 (500 nM) 24 h 
and / or w ith EGF (1 0 ng per ml) for 20 min. (c) ConAuent keratinocyte cultures in standard medium were treated with PD 153035 (500 nM) 24 h and/or EGF 
(1 0 ng per ml) for 20 min. Cell extracti on, immunoprecipitacion , phosphotyrosine antibody immunoblotting, and visualiza tion we re performed as described in 
!Vlatcrinls and i\1ethods. 
or EGFR M oAb to rapidly dividing, subconfluent keratinocytes 
induced expression ofK1 and KlO m arkers of termjnal differentiati o n 
within 48 h (Fig 3); however, PD153035 induced K1 and K10 m.R.NA 
expressio n earli er than EGFR MoAb. In addition, PD 153035 is a 
more rapid and potent inducer of Kl and K 1 0 gene express io n 
co mpared w ith EGFR. M oAb. These data also show that th e indu ctio n 
of expression of selected genes of terminal di ffe rentiation by PD 
153035 and EGFR MoAb is linked to growth inhibition and loss of 
donogenicity in keratinocytes (see Fig 2). 
Regulation of K1 expression by PD153035 at subconfluence 
or confluence and reversal by EGF during early stages of 
keratinocyte terminal differentiation Effects of EGF and cell 
density on expression of Kl by PD 153035-trea ted keratinocytes 
were also examined in undifferentiated, subconfluent cultures and in 
con flu ent cultures where cells have initiated terminal differentiation. 
Kl mRNA express i.o n was indu ced in subconflue nt cells after 24 h 
exposure to PD 153035 (Fig 4 , lar1 cs 1 and 2). EGF addition for 
4 h to PD 153035-treated keratinocytes (24 b) resulted in minimal 
suppression of l{ 1 mRNA express io n (Fig 4 , lane 3); however, when 
PD 153035 was removed and complete m edium containing growth 
factors was added for 24 h , inhibition of Kl mRNA expression was 
more pronounced (Fig 4 , lane 4). 
As previo usly shown, 1<1 mRNA expression was indu ced in cultures 
of keratinocytes reaching conAu ence (Pournay and Pittelkow, "1995). 
T he e ffect of PD 153035 o n levels ofK1 transnipt in conAuent cultures 
was detennined. K1 mR.NA levels were enhan ced approximately 3-
fo ld by PD 153035 trea tm ent compared with co ntro l cultures (Fig 4 , 
lanes 5 IJS 7 and larrcs 6 /JS 8) at 24 and 48 h of exposure. These results 
demonstrate that induction of terminal di~fferentiatio n , as measured by 
Kl gene express io n , was partially reversible foll.owing rem oval of PD 
153035 and addition of growth f.1 ctor-containin g medium. Further, in 
co nAuent, d ifferentiating keratinocyte cultures, I<.J gene exp ressio n 
was significantly en hanced by inhibition of HER-1 activity at a rate 
approxj mately three tim es that of control cultures. 
Inhibition ofEGF-induced HER-1 autophosphorylation by PD 
153035 in subconfluent or confluent keratinocyte 
cultures Activity of HER- 1 is m ediated through ph osp horylati o n 
of specifi c ty ros ine residu es w ithin the cytoplasmjc domain of the 
transmembrane receptor. We therefore exa m.in ed th e steady-state levels 
of 1:-lER-l autophosphorybtion in untrea ted o r trea ted cultures at 
subco nfluence o r confluence. Autonomously repli ca ting keratinocytes 
showed a high baseline level of autophosph o rylated (activated) 1-IER-
1 (Fig Sa.) . Within 8 h of treatment, autonomous HER- I. autophospho-
Ly lati o n was markedly reduced by PD 153035 in subconflu ent cells, 
and partial recovery to basebne levels of phosphoryla ted receptor was 
seen over 24 h. EGF addition to PD 153035-trea ted, subconfluent 
keratinocytes did not significantly alter the level of autophosphoLylated 
1-lE.R.-1 (Fig 5b); however, simjlar to results examining DNA synthesis 
and difFerentiation, removal of PD 153035 and trea tment of cultures 
with EGF markedly enhanced levels of HE.R.-1 autophosphoLy lation. 
1-IER-l autophosphOLylation was also analyzed in conflu ent cultures 
of keratinocytes that are undergoing terminal differentiation. PD 
153035 almost completely abrogated the lower baseline levels of 
autophosphOLy lated 1:-lER-1 in confluent differentiating kera tinocyte 
cultures and suppressed stimulation of HER-1 phosphotylation by 
EGF (Fig 5c). Removal ofPD 153035 restored th e ability of co nAu ent 
cultures to respond to EGF as m easured by enhanced HER-1 autophos-
photy!ation (data not shown). 
D ISC U SS ION 
Human keratinocyte proliferation, growth arrest, conunitment, and 
tennin al differentiation are highly coordinated and intLicate biologic 
p rocesses for w hich specifi c ce llular control mechanisms are being 
elucidated. Mediators of proliferation and/or differentiation in 
kera tin ocytes inc lude cell shape and size (W att eta/, 1988), cell dens ity 
(Wille e/ a/, 1984; Po umay and Pi ttelkow, 1995) , integrin expression 
and subunit acti vatio n (Symington and Carter, 1995 ; Tennenbaum 
ct a/, "1996), basement m embran e and extracellular matrix interac tions 
(Adams and Watt, 1989; Watt eta/, 1993; Li ct a/, 1996), intra 
and extrJCe!Jular concentrati o ns of calcium (Eckert, 1989), signaling 
e nzym es such as protein kinase C (Denning eta/, 1995), transcripti o n 
factors (Ga ndarillas and Watt, 1995), cell surface receptors including 
the adrenergic and G-pwtein coupled system (Schallreuter eta/, 1995), 
and p eptide growth f.1cto rs such as transfo rming growth factor-~ , EGF-
related liga nds, keratinocyte growth f.1cto r, and insulin- like growth 
factors (Shipley eta/ , 1986; M archese et a/, 1990). 
The ro le of HE.R.-1 in kerati nocyte pro li feration is well documented 
(Cook ct a/, 1991 b; Pittelkow cf a/, 1993) . The density of HER- ".! is 
greatest in the basal, ge rn1inative compartm ent of the epidermjs. With 
epidermal diffe rentiatio n , H E R.-1/EGF.R. expression is downregulated 
but remain s elevated in hyperproliferative sbn diseases such as psoriasis 
and sq uam o us ce ll carcino ma (Nan ney ci a/, 1986; G roves ct a/, 1992; 
Grandis et a/, 1996) . 
The present in vestiga tions directly demonstrate that inhibition of 
ligand binding and bnase activa tio n of HER- l in keratinocytes is also 
coupled to growth arrest, irreversible loss of clo nogenic potential (cell 
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commitment), and induction of tenni nal differentiation. These studies 
provide further evidence that autocrin e proliferation of keratin ocytes 
is mediated in large part, if not solely, by endogenously produce_d 
EGF-related li gands that bind and activate HER-1. 
The overlappi11 g or redundant functions of EGF-related ligands in 
epidermis likely account for the unanticipated findin g that transformin g 
growth fa ctor-a: null o r the spontaneous waved-1 mutati on exhibit 
only minimal epithelial alterations related to abnorma l and delayed hair 
germ formation and waved hair (Luetteke et a/, 1993; Mann et a/, 
1993) . Mice harboring the closely related waved-2 mutation have 
subsequently been found to have a single nucleotide transversion within 
EGFR tyrosin e kinase domain and diminished receptor tyrosin e kinase 
activity (Luetteke et a/, 1994). R ecent characterization of EGFR-null 
nuce have more precisely identifi ed the fun ction of H ER-1/EGFR in 
epidermis and o ther epitheli al tissues/ orga ns. Gene targeting to create 
a null aLl ele at the EG FR. locus has been reported by several groups 
(Mietti nen et a/, I 995; Sibilia and Wagner, 1995; Threadgi ll et a/, 1995). 
Peri-implantation dea th was frequ ent; however, viable mutants showed 
markedly thinned epidem1is, prominent stratum granu losum, and a 
dramatic decrease in epidermal keratinocyte replica tion. These findin gs 
implicate a critical role for EGFR in both keratinocyte growth and 
differentiation. 
Another family of receptor tyrosine kinase inhibitors, the tyrphostins, 
have been shown to inhibi t EG F-dependent pro liferation 1n 
keratinocytes (Dvir et a/, 1991 ); however, the 1C 50 for PD 153035 is 
at least severa.l orders of magnitude more potent than the tyrphostins 
(Fry ct a/, 1994; Levitzki and Gazit, 1995). HER-·1 aurophosphorylation 
recovery also suggests that PD 153035 is metaboli zed or inactiva ted 
by keratinocytes over 24 h exposure . Keratin ocytes are metabolically 
active and continue to synthesize HER-1 , but co ncentrations of PD 
153035 used are several log-orders greater than the IC 50 and wou ld 
inlubit newly syn thesized receptor. Other recent studies i11 vitro and 
i11 r1ivo also indicate that PD 153035 is a reversible inhibitor with a 
very slow off-rate (a nd vety tight binding) and is metabolized (Bridges 
eta/, 1996; Kunkel et a/, 1996). This keratinocyte culture model may 
be useful to further characte rize receptor dynami cs (synthesis and 
activation) and drug metabolism/ inactiva tion i11 vitro. 
Inhibition of prolifera tion by PD 153035 and EGFR MoAb indu ces 
loss of clonal potential within 24 h, and the effect is more rapid for 
PD 153035 than EGFR MoAb. Restimulation of DNA synthesis 
fo !Jowing removal of PD 153035 and addition of EGF is an early but 
short-lived response in treated keratinocytes. Clonal growth is more 
stringent and requires multiple rounds of repLication and cell division 
to generate macroscopic coloni es. It is likely, therefore, that PD 153035 
treatment comnuts clonogenic keratinocytes to transient amplifying 
cells that are able to undergo only a few rounds of DNA synthesis. 
Together, these results demonstrate that the functi onal inactivation 
of HER-1 in undi ffe rentiated, basal-like keratinocytes by specific 
inhibitors triggers an orderly sequence of decreased HER-1 autophos-
phmy lation, cell cycle growth arrest, keratinocyte commitment, and 
initiation of terminal differentiation. Inhibition of HER-1 tyrosine 
kinase activity by PD 153035 in differentiating keratinocytes also 
Fnhances temunal differentiation as assessed by expression of K1 
and K10 genes. This culture model of keratinocyte growth and 
differentiation will be useful in future investigations to elucidate the 
fun ctional activities of EGFR in epidermal homeostasis. Epidermal 
atrophy, hyperplasia, and abnormal differentiation observed in various 
sk.in diseases may be mediated through disruption of the EGF-related 
ligand/ HER-·1 signaling cascade. These present results also suggest that 
downregulation of EGFR activity by sma.ll molecu le inhibitors may 
exert therapeutic benefit in benign epidermal hyperproliferative diseases 
or malignant cutaneous carcin om'as where dys regulated growth is 
mediated through EGFR (Pitte lkow, 1991 ; Levitzki and Gazit, 1995; 
Levitzki, 1996). 
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